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Single ventricle heart defects are a serious subset of congenital heart defects 
(CHDs) caused by the underdevelopment of one side of the heart. Many of these 
univentricular CHDs are treated with a combination of palliative surgeries, culminating in 
the Fontan procedure. These Fontan patients lack cardiac support between the systemic 
vascular return and pulmonary system. Several researchers have suggested a 
cavopulmonary assist device to reverse the hemodynamic decay experienced by these 
patients.  
A peristaltic-style flow pump could be a possible solution as a cavopulmonary 
assist device. Such a novel flow pump uses balloons to produce forward flow by 
squeezing a graft in individual actuation zones. In this study, the mechanics of this pump 
are computationally modeled so that, given a set of boundary pressure conditions, the 
model calculates the impact of the device on the surrounding flow rates. In the future, this 
computational model can be placed in a full body lumped parameter network (LPN) to 
identify the effect this flow rate impact has on patient hemodynamics. This model was 
tuned using two sets of experimental data and validated with six additional data sets. A 
good qualitative match was achieved in the tuning data sets and four of the validation 
sets. These data sets had NMRSE values between 19% and 27%. A poor qualitative 
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Univentricular congenital heart defects (CHDs) are a serious subset of congenial 
heart defects where only one ventricle fully develops. These single-ventricle defects are 
estimated to occur in 0.08 to 0.4 per 1,000 births and account for 7.7% of CHDs 
diagnosed [1]. The physiology of the defect can manifest in a variety of diseases but can 
be caused by underdevelopment of heart valves or entire sides of the heart. If unoperated 
on, 70% of patients with well-formed single left ventricles died prior to age 16 with a 
4.8% annual attrition rate. Patients with poor right ventricular morphology had a 50% 4-
year survival rate [2].   
In the past 50 years, the standard of care for these diseases has improved 
substantially. Three stages of palliative surgeries were developed in the 1970s to enable 
single ventricle patients to survive until adulthood. The Fontan procedure is the 
culmination of these surgeries, where deoxygenated venous return flow is normally 
routed directly to the pulmonary arteries rather than passing through the right atrium and 
ventricle. This can be accomplished partially, resulting in deoxygenated and oxygenated 
blood mixing, or totally, where an extra-cardiac graft is used to circumvent the right 
atrium. The total cavopulmonary connection (TCPC) with an extracardiac conduit (ECC) 
is the current standard of care. The systemic circulation is supported by connecting the 
single ventricle to the aorta in the first of these staged surgeries. The entire combination 
of surgeries is initiated within the first two weeks of life, and the Fontan procedure is 
usually completed when the patient is between 18 months and 4 years old [3], [4].  
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In a 2015 follow-up study with their Fontan patients from the previous 40 years, 
physicians at the Mayo Clinic saw survival rates of 74% at 10 years, 61% at 20 years, and 
43% at 30 years. Survival has continued to improve with surgical techniques, increasing 
to a 95% 10-year survival rate for patients operated on since 2001 [5]. However, due to 
its palliative nature, many Fontan patients have a decreased quality of life, including 
reduced exercise capacity and poor hemodynamics contributing to decreased late-stage 
survival. These hemodynamic complications, including high central venous and caval 
pressures in the inferior vena cava (IVC), lower pulmonary pressure and cardiac output, 
and low arterial oxygen saturation, can lead to hepatocellular carcinoma and hepatic 
fibrosis and cirrhosis leading to liver failure, as well as renal and circulatory dysfunction 
and failure [6]–[8].  
In 1998, to address these complications caused by elevated venous pressure, De 
Leval proposed a mechanical cavopulmonary assist device to be inserted directly into a 
patient’s ECC. A device that could improve caval hypertension and pulmonary arterial 
hypotension by 5 mmHg would be enough to substantially improve patient results [9]. In 
2011, Rodefeld et al. discussed the limitations of current technology as it would apply to 
an inline assist device. Current axial or centrifugal flow devices operate at high rotational 
speed with blades in contact with blood, leading to hemolysis and thrombosis, as well as 
a negative inlet pressure leading to suction collapse of the vena cava. In addition, these 
devices would be completely obstructive upon failure, so the device could not be shut off 
[10].  
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One possible solution for a cavopulmonary flow assist device is a novel, nonaxial 
linear flow pump. A ventricular assist device (VAD) of this nature uses a peristaltic 
motion to move fluid in a staged, wave-like motion through a graft, like the motion of a 
digestive tract. Forward flow is achieved by occluding the graft in stages, moving fluid 
downstream and preventing retrograde flow. This compression is ideally symmetrical 
over the radius of the graft. There are several benefits of a device of this design. In 
addition to no blood contact by the working surfaces, the device can be attached directly 
to the patient’s blood vessel or graft without an additional surgery or cutting additional 
vessels. The pump can remain off until it is needed. 
A device of this design was fabricated and tested by Frankman et al. Their device 
produces forward flow via the actuation of balloons surrounding a graft. These balloons 
are actuated on ten individual zones using predefined algorithms. Air was supplied to 
each balloon via a system of solenoids. One-way flow was achieved by using the 
balloons on the outer edges of the device to act as valves. The researchers were able to 
achieve forward flow but with only a maximum mean flow rate of 3.2 L/min against a 
normal systemic pressure gradient. At rest, a normal systemic cardiac output is around 5 
L/min. However, the pulmonary circulation has a less extreme pressure gradient, so this 
device may be able to achieve physiologically realistic flows at those pressure gradients 
[11].  
The goal of this project was to develop a computational model of a peristaltic 
VAD device in MATLAB, then verify and validate the model using experimental data 
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from Frankman et al. The objective of the verification and validation was to obtain a 
good qualitative comparison between the model’s results and the experimental data. 
With the construction of this model, the physiological impact of this type of VAD 
can be measured. When the model is placed into a full-body lumped parameter network 
(LPN) [12], boundary pressure conditions from the LPN can be used by the model to 
calculate the downstream flow rate produced by the device. The model’s insertion into 
the LPN will enable the discovery of the pump’s ability to decrease caval pressure, 
increase pulmonary arterial pressure, and look at its effect on blood flow throughout the 
body. It will also enable the possible implementation of feedback control of the flow rate 
produced by the device. Finally, it will help develop design parameters the device needs 








The computational model is based off lumped parameters models, in that the 
pattern of blood pressure and flow during a cardiac cycle can be modeled using electrical 
circuit representation. Voltage is used to represent blood pressure and current to represent 
blood flow, while resistance is vascular resistance. Capacitance is used to represent the 
compliance of large vessels, or their ability to swell to an increased volume as pressure 
increases. Finally, the momentum of blood is represented by inductance [13]. The 
computational model of the VAD is made up of two parts, shown in Figure 1: a logic 
model (LM) of the device stages and a set of lumped parameter elements to calculate the 
flow into and out of the LM. In Figure 1, the components included within the “LM” box 
are modeling the stages of the device. Outside the “LM” box but still within the device 
model are the lumped parameter elements responsible for calculating the effect the LM 
has on the flow into and out of the device. Pin and Pout are the boundary conditions to 
the LM. Pup and Pdown are the boundary conditions to the entire model. 
 
Figure 1: Diagram of simplified model 
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Logic Model 
The LM keeps track of the stage volume and calculates the flow into, out of, and 
between the stages of the device, depending on the boundary pressure conditions, applied 
air pressure to the stages, and the pumping algorithm chosen. These pumping algorithms, 
of which a simplified version of the “High flow” algorithm is presented in Figure 2, are 
imported into the LM to define a stage as receiving the supplied air pressure, “pressure-
on”, or not receiving any supplied air pressure, “pressure-off”. These patterns of 
“pressure-on” or “pressure-off” are directly from Frankman et al.’s pumping algorithms 
and are dependent on time. In the example in Figure 2, during the filling phase, stages 
one, two, and three are “pressure-off”, while stage four is “pressure-on”. Next, during the 
trap phase, stage one is “pressure-on”, while stages two, three, and four are “pressure-
off”. Based on predetermined logic, presented in Figure 3, the LM determines if each 
stage is filling, ejecting, empty, or letting flow pass through. It is important to note that 
the simplified diagram and algorithm in Figure 1 and Figure 2 are not exactly 
representative of the computational model but are a simplification.  This simplification is 
possible because in the ten-stage device, stages two-eight operate in the same manner. 
They can be collapsed into stages two and three in the simplified figures. 
 
Figure 2: Simplified “High flow” algorithm 
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In Figure 3, the LM logic diagram, the main decision points are marked with 
Arabic numbers to aid explanation. Stage volumes and pressures are indexed with “i” to 
identify the current stage ejecting or filling from outside the device and are indexed with 
“j” to identify the filling stage towards which the ith stage is ejecting. The first decision 
point checks whether air pressure is being applied to the stage or not. For all “pressure-
on” stages, the LM checks for downstream flow first, then rechecks for upstream flow. If 
a stage is “pressure-on”, that stage is ejecting, unless its volume is zero, which means it is 
already empty. This is checked at decision point two. If the stage is not empty, continuity 
is checked to the outside of the device at decision points three and four. Continuity means 
there is an unabridged connected between the ejecting stage and outlet of the LM; all 
stages between the stage in question and the outlet of the LM are not empty and not 
filling.  If there is continuity to the outlet of the LM, the LM directs flow in that direction. 
If the continuity condition is false, there is a check at decision point five for connection to 
a filling stage, where the ejecting stage is providing flow towards a non-full stage. A 
good example of a situation where a single stage is “pressure-on”, but ejecting flow in 
multiple directions, is during the trap phase of Figure 2, where stage one ejects volume 
both to the LM inlet due to continuity and to stage four in a filling connection. 
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Figure 3: Logic Diagram of the LM 
 
If the stage is defined by the pumping algorithm as “pressure-off”, the LM checks 
for stages filling from the LM inlet or outlet. It does this by finding the first non-full stage 
at decision point 6, then at decision point 7, checking if it is connected to the head or tail 
of the LM. If these two checks yield a result, that filling flow is directed to the 
corresponding stage. The LM does not need to check for filling from another stage, as 
that is covered in the “pressure-on" checks.  
LM Flow Matrix  
The LM keeps track of the flow from into the LM, out of the LM, or between 
stages by developing a flow matrix, here simplified to the same level as Figure 1 and 
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Figure 2 and presented in Figure 4, that relates where flow is coming from to where it is 
going. Each “X” denotes that a stage’s flow cannot go to and from itself. For example, in 
Figure 2’s filling phase, where stages one, two, and three are filling from the LM inlet, 
cells B1, C1, and D1 would have positive values. In Figure 2’s trap phase, where stage 
one ejects flow to the LM inlet and into stage four, in addition to stage four backfilling 
from the LM outlet, cells A2, E2, and E6 will have positive values. All other cells would 
be zero, therefore, there will be no negative values in this flow matrix.  
   A B C D E F 










)  in S1 S2 S3 S4 out 
1 in X      
2 S1  X     
3 S2   X    
4 S3    X   
5 S4     X  
6 out      X 
Figure 4: Simplified LM flow matrix between stages and upstream/downstream 
 
For every time step the LM determines the direction of flow to and between 
stages via the logic shown in Figure 3, identifying flow for each stage as either continuity 
ejection, stage-filling ejection, or filling from outside the device. For ease of 
understanding, the definition of these flow direction phrases is included in Table 1.  The 
LM then calculates the flow using equations whose terms depend on the direction of flow 
and what each stage is connected to. As an example, for a stage ejecting to the LM outlet, 
the stage pressure will be compared to the outlet pressure.  These equations rely on a 
fundamental equation for lumped parameter models shown in equation (1), which is like 
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Ohm’s law but applied to fluid mechanics. R is the stage resistance, Q is the flow across 






The resistance of each stage is calculated depending on the volume of the stage, 
where a decrease in volume causes an increase in resistance, shown in equation (2). C is a 
constant, V is the stage volume, and Rmin is the minimum resistance when the stage is at 
max volume and fluid is passing through the stage. The equation is constructed in this 
way because a completely open stage with high volume will provide low resistance, but 
as the stage begins to close and volume decreases, the resistance will increase. An empty 
stage will have high resistance, which will prevent fluid from passing through this empty 
stage. In addition, resistance is proportional to vessel diameter to the fourth power [13]. 
As volume is proportional to diameter cubed, the stage resistance is calculated 
proportionally to volume to the 4/3rd power.  















Air Pressure Flow Direction Definition Equation Number 
“Pressure-
on” 











Filling of stage from inlet 
or outlet (7) & (8) 
Table 1: Definitions of LM flow directions  
 
Once the direction of flow has been identified by the LM via the logic in Figure 3, 
that flow is calculated by the following equations. For the continuity ejection cases, 
shown at decision points 3 and 4 in Figure 3, flow is calculated by equations (4) and (5). 
Q(S(i), in) and Q(S(i), out) are flow from the ith stage towards the inlet or outlet, 
respectively. P(i) is the applied balloon pressure of the ejecting stage and it calculated in 
equation (3), where Pact is the supplied actuation air pressure to each stage and Ploss is the 
pressure loss percentage to account for losses in the system.  Pin and Pout are the inlet 
and outlet pressure, respectively, and ΣR is the sum of the resistances between the 
ejecting stage and the inlet or outlet. For example, if stage 2 is ejecting to the outlet of the 
LM, the sum of the resistances would include stage 3, stage 4, and a downstream ejection 
resistance.  
 𝑃𝑃(𝑖𝑖) = 𝑃𝑃𝑎𝑎𝑎𝑎𝑎𝑎 − (𝑃𝑃𝑎𝑎𝑎𝑎𝑎𝑎 ∗ 𝑃𝑃𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙)  (3) 
 
 













Continuing with stage ejection cases, a flow connection to a filling stage up or 
downstream, shown at decision point 5 in Figure 3, is calculated in equation (6). Q(S(i), 
S(f)) is the flow from the ith stage to the fth stage. P(i) and P(f) are the applied balloon 
pressures of the ejecting and filling stages respectively. The filling stage will always have 
a lower pressure for flow to be driven to that stage. 
 






 For stages filling from the inlet or outlet of the device, shown at decision points 7 
and 8 of Figure 3, the flow is calculated in equations (7) and (8). Q(in, S(H)) and Q(out, 
S(T)) are the flow from the inlet or outlet to the stage connected to the head or tail of the 
device, respectively. P(H) and P(T) are the applied balloon pressures of the filling stages 
connected to the head or tail, respectively. These pressures will always be less than the 
inlet or outlet pressure for flow to be driven into the stage. For all these flow calculations 
in equations (4)-(8), the calculated flow is added to the current value of flow at that 
timestep in order to account for multiple flows into or out of each stage.  












Because the stages are interconnected and using the flow matrix in Figure 4, the 
flow into a stage is defined as the mean of its column and the flow out of a stage is 
defined as the mean of its row. For example, the flow into stage 1 would be the mean 
value of column B, while the flow leaving stage 1 would be the mean value of row 2. 
 13 
These are shown in equations (9) and (10), where Qin(S(i)) is the inflow to a stage, 
Qout(S(i)) is the outflow from a stage, Q is the flow matrix, and i is the stage number. The 
change in volume of each stage can then be calculated with equation (11), where 
dV/dt(S(i)) is the change in volume of a stage. 
 𝑄𝑄𝑚𝑚𝑚𝑚(𝑆𝑆(𝑖𝑖)) = 𝑚𝑚𝑚𝑚𝑚𝑚𝑖𝑖(𝑄𝑄(: , 𝑆𝑆(𝑖𝑖))) (9) 
 




(𝑆𝑆(𝑖𝑖)) = 𝑄𝑄𝑚𝑚𝑚𝑚�𝑆𝑆(𝑖𝑖)� − 𝑄𝑄𝑙𝑙𝑜𝑜𝑎𝑎(𝑆𝑆(𝑖𝑖)) 
(11) 
 
The same concept can be applied to calculate the flow into and out of the LM, 
shown in equations (12) and (13). QI and QO are the flow into and out of the LM. The 
row and column references flip for equations (12) and (13) because as positive flow is 
considered from the inlet of the LM towards the outlet of the LM. These QI and QO 
values are passed from the LM to the lumped parameter elements of the model in order to 
calculate how these values are affected by upstream and downstream pressure, blood 
momentum, and blood vessel compliance. 
 𝑄𝑄𝑄𝑄 = 𝑚𝑚𝑚𝑚𝑚𝑚𝑖𝑖�𝑄𝑄(𝑖𝑖𝑖𝑖, : )� − 𝑚𝑚𝑚𝑚𝑚𝑚𝑖𝑖�𝑄𝑄(: , 𝑖𝑖𝑖𝑖)� (12) 
 
 𝑄𝑄𝑄𝑄 = 𝑚𝑚𝑚𝑚𝑚𝑚𝑖𝑖�𝑄𝑄(: , 𝑜𝑜𝑜𝑜𝑜𝑜)� − 𝑚𝑚𝑚𝑚𝑚𝑚𝑖𝑖�𝑄𝑄(𝑜𝑜𝑜𝑜𝑜𝑜, : )� (13) 
 
Lumped Parameter Elements  
In order to calculate the LM’s effect on blood flow into and out of the device, 
visualized in Figure 1 as upstream and downstream flows Qup and Qdown, the model relies 
on two additional equations fundamental to the lumped parameter models. Equation (14) 
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relates the change in flow Q, over an inductance L, to a change in pressure P. Equation 


















The LM’s effect on the upstream and downstream flows must be calculated by 
relating the upstream and downstream pressures outside the device to the pressures at the 
inlet and outlet of the LM, shown in equations (16) and (17) by using equation (14). 
These inlet and outlet pressures are calculated in equations (18) and (19) by using 
equation (15). In order to better replicate downstream flow conditions, a second 
capacitance was added between the downstream inductor and resistor to dampen the 
downstream flow; the pressure at this second capacitor is calculated via equation (20).  
Here, Qup and Qdown are the upstream and downstream flow outside the LM, 
respectively. Pup and Pdown are the boundary condition pressures of the entire model, 
while PO is the pressure at the secondary downstream capacitor. RU and RD are the 
resistances opposing filling and ejection both upstream and downstream. L is the 
inductance at the upstream and downstream inductors, representing blood momentum. C 
and C2 are the capacitance values at the upstream and downstream capacitors, 















































These elements in equations (16)-(20) are tracked by the model using an RK4 
algorithm to keep track of the value of each variable and the rate of change of each 
variable at each time step. Important data sets are then plotted to compare to known data. 
Tuning and Validation 
 In the testing of their device, Frankman et al. produced experimental results for 
the downstream flow for a variety of their pumping algorithms. This downstream flow is 
represented in the computational model as Qdown and is used as the tuning output from the 
model. The researchers defined several constant values, which were used as 
predetermined parameters for the model. These values were upstream and downstream 
pressure Pup and Pdown, applied balloon air pressure P(i), and the timing of the different 
pumping algorithms. Several parameters were used to tune the model to adjust the 
model’s downstream flow to match the goal downstream flow, given different predefined 
parameters. These tuning parameters were a pressure loss percentage Ploss, which 
quantified the possibility all the applied air pressure would not be applied to the fluid 
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inside the graft, the minimum resistance value of a stage Rmin, the upstream and 
downstream resistances RU and RD, the blood inductance L, and the vessel capacitances C 
and C2. These parameters can all be found on the diagram of the simplified model in 
Figure 1, except for Rmin, shown in equation (2) and Ploss shown in equation (3). All the 
algorithm timings are shown in Figure 5. 
The goal of the manual tuning was to generate a good qualitative result for the 
downstream flow Qdown, when comparing the model’s result and the experimental data. 
This would, in turn, reduce the error. The normalized root mean squared error (NRMSE) 
was used as the cost function for tuning. It was calculated using equation (21), where ŷ is 
the data from the computational model, y is the goal, experimental data, and T is the total 












Frankman et al. used four pumping algorithms to test the device, as well as a 
timing and movement test. These algorithms are shown in Figure 5. The results of several 
tests completed by the researchers are shown in Figure 6. They achieved these results by 
tracking individual particles in the fluid with high frame rate video analysis. The data was 
digitized from the plots using the online plot digitizer at https://apps.automeris.io/wpd/.   
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Figure 5: Frankman et al.’s pumping algorithms [11] 
 
The model was tuned using the results of the “Timing and movement test”, as 
well as the “High flow” algorithm with a 12.5psi actuated air pressure. This air pressure 
was used for tuning the “High flow” algorithm because Frankman et al. suggested it was 
the minimum air pressure “required for the actuation zones to quickly and completely 
occlude using the existing prototype”. In addition, the experimental data includes average 
flow rates for only the 12.5 psi “High flow” algorithm. The computational model was 
tuned based on zero pressure gradient, given as a 120 mmHg upstream and downstream 
pressure. This is the pressure gradient used in all experimental data plots in Figure 6. 
The tuning was tested on a 30-second interval with a time step of 0.001 seconds. 
A 30-second interval was used to determine how the model would stabilize after several 
time cycles. However, the experimental results only include data for four to seven 
seconds, so the plots are truncated to reflect this. Tuning began with the filling and 
ejection timing, shown in Figure 6(B), by adjusting all the tuning parameters: Ploss, Rmin, 
RU, RD, L, C, C2. Frankman et al. used the “High flow” algorithm in this “filling and 
ejection timing” test but changed the time allowed for stages to fill and eject. During the 
filling phase of the adjusted “High flow” algorithm, the tuning parameters were adjusted 
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to allow the nine open stages of the device to fill in just under 0.8 seconds. The same was 
done during the bulk movement phase of the device to allow the 8 closing stages to eject 
in around 0.75 seconds. These results enabled the device to empty and completely refill 
for every time cycle for the entirety of the 30-second tuning test. 
These two tuning results coexisted well, however, when tuning moved onto the 
12.5 psi “High flow” algorithm, the instantaneous downstream flow did not match. In 
order to bring the flow rate to a more reasonable value, some tuning parameters were 
updated. The parameters updated included RU, RD, L, and C, while Ploss, Rmin, and C2 
remained unchanged. In the “Filling and ejection timing” test, the stages had 0.8 seconds 
to fill, while in the “High flow” algorithm, they have 0.4 seconds to fill. With less time to 
fill, the middle stages of the device model had a net decrease in volume as soon pumping 
began. This caused stages six and seven to bottom out at the minimum stage volume after 
just four time cycles, preventing flow through those stages and making it impossible to 
generate a positive downstream flow rate.  While measurements of stage volumes were 
not available in the experimental data, the measured downstream flow rate appears to 
match the model results if we assumed that the experimental data was from the first time 
cycles after the device was turned on, and that the stages of the device started full rather 
than empty. The results of the 12.5 “High flow” algorithm tuning are shown in Figure 7, 
where a NMRSE value of 22.9% percent was obtained. 
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Figure 6: Presented results for experimental data [11]. (A) Shows results for three algorithms from Figure 5 
at a supplied air pressure of 12.5 psi. (B) Shows the results of the “Filling and ejection timing” test, which 
was used to tune the LM. (C) Shows an example of a test of the “High flow” algorithm, where each shape 
is a different tracked particle. (D) Shows the performance of the “High flow” algorithm at difference 
supplied air pressures.  
 






After the computational model was tuned using the filling and ejection testing and 
12.5 psi “High flow” algorithm data, the tuning could be validated with other data sets 
from the experimental data. Four of these experimental data sets matched the goal data 
well; the 7.5, 10, and 15 psi “High flow” algorithms and the 12.5 psi “Delta function” 
algorithm, shown in Figure 8. These experimental data sets had similar NRMSE values to 
the 12.5 psi “High flow” tuning results and maintained a good qualitative match of the 
goal data for each of the algorithms.   
However, two of the experimental data sets did not match the goal data well. The 
“Double pulse” algorithm and “Peristalsis” algorithm, shown in Figure 9, both did not 
have a good qualitative match to the goal data set. The individual peaks are too frequent 
and dramatic, which suggests the capacitor and inductor values may be incorrectly tuned. 
These experimental data sets had NRMSE values significantly higher than both the 
tuning data sets and well-matched experimental data sets. 
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Figure 8: Well-match data validations sets. (a) 7.5 psi “High flow” algorithm - NSRME = 21.9%. (b) 10 psi 
“High flow” algorithm – NSRME = 27.7%. (c) 15 psi “High flow” algorithm – NSRME = 23.4%. (d) 12.5 
psi “Delta function” algorithm – NSRME = 19.8%. 
 
 
Figure 9: Poorly matched data validation sets. (a) 12.5 psi “Double pulse” algorithm – NMRSE = 30.4%. 










One of the main motivations for this style of cavopulmonary pump is that it would 
not contact the blood it is pumping. The main benefits from this would be low hemolysis 
and thrombosis generated by the device. In addition, the device could be implanted 
directly on the ECC during the same surgery where the ECC is implanted. It could remain 
off and not used until needed. This is unlike most devices on the market today, which use 
axial or centrifugal impellers that directly contact blood. These devices need to be on 
continuously, or they would cause significant damage due to the blockage of flow.  
Recently, in June 2021, a centrifugal pump designed specifically for 
cavopulmonary assist was tested by Escher et al. at hemodynamic conditions relative to 
Fontan patients. This device would be installed at the four-way Fontan junction, where 
the superior and inferior vena cava meet the left and right pulmonary arteries. Both the 
Frankman and Escher cavopulmonary flow pumps ran an in-vitro hemolysis assay using 
pig and bovine blood respectively. Frankman et al. ran their axial balloon pump at 3 
L/min and 60 bpm at 120-mmHg upstream and downstream pressure for one hour. They 
saw an average plasma free hemoglobin value, a marker of hemolysis, of around 32 
mg/dL at 60 minutes. Escher et al. ran their centrifugal pump at 4 L/min and 2500 rpm at 
around 15-mmHg pressure for six hours. At 60 minutes, saw an average plasma free 
hemoglobin value of around 2.5 mg/dL. At six hours, the average plasma free 
hemoglobin value rose to 14 mg/dL [11], [14].  
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Although Escher et al. present hemolysis results for the centrifugal pump that are 
significantly better than Frankman et al.’s balloon pump, the centrifugal pump design is 
based on current blood pumps that are leaders in their market. The centrifugal pump was 
well designed and fabricated, and it was tested in a high-quality study. The balloon pump 
was a proof of concept device, based on a new concept for pumping blood. Although the 
balloon pump’s plasma free hemoglobin average is an order of magnitude greater than 
the centrifugal pump, these numbers could be significantly improved on future iterations 





CONCLUSIONS AND FUTURE WORK 
 
 
As seen through the tuning and results, this modeling strategy works for most 
algorithms, namely the “High flow” at various pressures and the “Delta function”. The 
model seems to cover the nuances of the downstream experimental flow data. For the 
algorithms with poorly matched data, the “Double pulse” and “Peristalsis” algorithms, 
retuning of various tuning parameters would benefit the model.  The error seen in all 
algorithm cases could probably improve.  
Once the model has been further optimized, it can be inserted into a full-body, 
closed loop LPN to determine the pump’s effectiveness. This LPN has been shown to 
accurately model trends in physiological parameters throughout the body [12]. It can then 
be used to determine the effectiveness of a pump of this design at alleviating caval 
pressures and boosting pulmonary pressure. If, through the LPN, it is determined that the 
balloon pump can provide substantial benefit to a patient, design parameters can then be 
optimized to provide maximal hemodynamic benefit. For instance, the optimal size of the 
stages and the device itself can be determined. Finally, a feedback control system can be 
put in place to control the flow rate through the device depending on parameters in the 
flow loop. 
To put it into context, a future version of this model could be used to calculate the 
effect a peristaltic pump of this style would have on a specific patient by using the full 
body LPN. Given specific hemodynamic parameters known about the patient, such as 
their current IVC and pulmonary pressures, or by using estimations developed based on 
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body size and other key markers, a physician would be able to see how this device would 
affect that patient’s cardiovascular system. In addition, if a device of this style is already 
implanted into a patient, their physician can change pumping algorithms or similar details 
in the model to experiment with blood flow rather than performing these experiments 
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